TrialCancer research and treatment2025

Combination Therapy of Pyrotinib and Metronomic Vinorelbine in HER2+ Advanced Breast Cancer after Trastuzumab Failure (PROVE): A Prospective Phase 2 Study.

Chunfang Hao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.